Search for: "TEVA SALES "
Results 61 - 80
of 487
Sorted by Relevance
|
Sort by Date
18 Jul 2018, 11:23 am
In its opposition to certiorari, Teva argued that post-AIA § 102 retained the term “on sale” unmodified, which covers confidential sales, and the claimed invention need not have been made public. [read post]
9 Sep 2007, 8:01 pm
Wyeth amassed $2.5 billion in sales of the heartburn medication for the sales year ending on June 30, 2007. [read post]
18 Jan 2006, 10:07 am
Teva Pharmaceuticals (Fed. [read post]
18 Jun 2018, 9:15 am
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
23 Jan 2019, 12:24 pm
Teva Pharmaceuticals wanted to market a generic palonosetron product in 2011. [read post]
15 May 2007, 9:34 pm
Aciphex has annual U.S. sales of over $1 billion and accounts for a large percentage of Eisai's U.S. revenue, so naturally Eisai filed suit against the generic applicants. [read post]
5 Feb 2019, 3:15 pm
Teva may seem like no big deal. [read post]
21 Apr 2008, 9:11 pm
Prevacid, a treatment for acid reflux, heartburn and stomach ulcers, had $3.4 billion in U.S. sales last year. [read post]
18 Aug 2013, 8:54 pm
Patent No. 8,058,398 ("Modified G-CSF Polypeptide," issued November 15, 2011) based on Teva's manufacture, use, and intended sale of, and filing of a Biologics License Application for, its Lonquex® (lipegfilgrastim, used to to... [read post]
28 Aug 2018, 5:15 pm
Teva Pharma USA, Inc. [read post]
22 Jan 2019, 1:37 pm
Teva Pharmaceuticals, the Supreme Court’s first patent case of the year, breaks no new ground. [read post]
23 Jan 2019, 10:00 pm
Teva Pharmaceuticals USA Inc., No. 17-1229 (2019). [read post]
30 Apr 2017, 10:00 pm
Teva, the Federal Circuit added greater clarity to the restrictions the sale of inventions pose to patentability. [read post]
10 Dec 2010, 1:14 pm
You would think that with Teva’s last quarterly net sales of $4.3 billion — an increase of 20% over the comparable period in 2009 — they could afford to put together a better game. [read post]
12 Mar 2008, 9:25 pm
Teva Pharms. [read post]
27 Nov 2018, 9:30 am
Teva challenged the validity of the patent, arguing that Helsinn’s sale qualified as prior art. [read post]
26 Jun 2018, 8:31 am
Teva case, which concerns whether the America Invents Act (“AIA”) changed the longstanding “on-sale bar” rule. [read post]
3 Mar 2019, 12:38 pm
Teva Pharmaceuticals USA, Inc., Docket No. 17-1229, J. [read post]
15 Mar 2016, 10:24 am
On appeal, Teva offers its set of arguments to retain the old-meaning: In ordinary usage, an item is “on sale” whether sold privately or publicly. [read post]
1 May 2017, 7:55 am
Teva (Fed. [read post]
